BioLife Solutions (BLFS) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free BLFS Stock Alerts $22.16 +1.50 (+7.26%) (As of 12:02 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 4:51 PM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $19.54BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $19.54May 13 at 9:47 AM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of "Buy" by AnalystsShares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12-monthMay 13 at 8:47 AM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Upgraded by Benchmark to BuyBenchmark raised shares of BioLife Solutions from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Monday.May 12 at 11:47 PM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) is Roubaix Capital LLC's 9th Largest PositionRoubaix Capital LLC grew its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 280,337 shares of the medical eMay 12 at 10:20 AM | finance.yahoo.comAnalysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest ResultsMay 12 at 2:53 AM | americanbankingnews.comStockNews.com Upgrades BioLife Solutions (NASDAQ:BLFS) to SellMay 11 at 2:04 AM | americanbankingnews.comBioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher After Better-Than-Expected EarningsMay 11 at 12:17 AM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Rating Increased to Sell at StockNews.comStockNews.com upgraded BioLife Solutions to a "sell" rating in a research note on Friday.May 10, 2024 | finance.yahoo.comBioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Issues Earnings ResultsBioLife Solutions (NASDAQ:BLFS - Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.06. The company had revenue of $31.73 million during the quarter, compared to the consensus estimate of $29.30 million. BioLife Solutions had a negative return on equity of 13.36% and a negative net margin of 46.37%. During the same period last year, the business posted ($0.27) EPS.May 10, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher on Better-Than-Expected EarningsBioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher After Earnings BeatMay 10, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Geneva Capital Management LLCGeneva Capital Management LLC reduced its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 874,485 shares of the medical equipmMay 10, 2024 | finanznachrichten.deBioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comBLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | investing.comBioLife Solutions Inc (BLFS)May 9, 2024 | msn.comBioLife Solutions GAAP EPS of -$0.22, revenue of $31.7MMay 9, 2024 | prnewswire.comBioLife Solutions Reports First Quarter 2024 Financial ResultsApril 30, 2024 | prnewswire.comBioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024April 28, 2024 | marketbeat.comJennison Associates LLC Lowers Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Jennison Associates LLC cut its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 39,978 shares of the medical equipment provider's stock after sellingApril 25, 2024 | investing.comBiolife Solutions exec sells shares worth over $8,900April 25, 2024 | investing.comBiolife Solutions exec sells shares worth over $5,000April 24, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Trading 4.2% Higher BioLife Solutions (NASDAQ:BLFS) Stock Price Up 4.2%April 24, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells 956 Shares of StockApril 23, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $14,636.36 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 956 shares of the firm's stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $15.31, for a total transaction of $14,636.36. Following the completion of the sale, the chief financial officer now owns 126,658 shares of the company's stock, valued at approximately $1,939,133.98. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.April 20, 2024 | investing.comBioLife Solutions divests Stirling freezer subsidiaryApril 20, 2024 | msn.comBioLife Solutions divest stirling freezer business to reduce cash burnApril 20, 2024 | insidertrades.comTodd Berard Sells 10,000 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockApril 19, 2024 | bizjournals.comBioLife Solutions lays off 47 workers after divesting cold storage businessApril 18, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Shares Up 5.4%BioLife Solutions (NASDAQ:BLFS) Trading 5.4% HigherApril 18, 2024 | finance.yahoo.comInsider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...April 18, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CMO Sells $156,700.00 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $15.67, for a total value of $156,700.00. Following the sale, the chief marketing officer now directly owns 129,644 shares in the company, valued at $2,031,521.48. The sale was disclosed in a filing with the SEC, which is available through this link.April 18, 2024 | prnewswire.comBioLife Solutions Announces the Divestiture of its Stirling Freezer BusinessApril 16, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Sees Significant Growth in Short InterestBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 3,200,000 shares, a growth of 5.6% from the March 15th total of 3,030,000 shares. Based on an average daily volume of 412,500 shares, the short-interest ratio is currently 7.8 days.April 9, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Trading 4.9% Higher BioLife Solutions (NASDAQ:BLFS) Trading 4.9% HigherApril 4, 2024 | markets.businessinsider.comBuy Rating on BioLife Solutions: Focused Growth and Market Leadership Post-DivestitureApril 4, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $17.32BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $17.32April 4, 2024 | marketbeat.comJefferies Financial Group Begins Coverage on BioLife Solutions (NASDAQ:BLFS)Jefferies Financial Group assumed coverage on shares of BioLife Solutions in a report on Thursday. They issued a "buy" rating and a $22.00 price target on the stock.April 4, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 4,000 Shares of StockApril 3, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells $70,600.00 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 4,000 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $17.65, for a total transaction of $70,600.00. Following the completion of the sale, the insider now directly owns 65,843 shares of the company's stock, valued at $1,162,128.95. The sale was disclosed in a filing with the SEC, which is available through the SEC website.March 31, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest UpdateBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 3,030,000 shares, a decrease of 7.6% from the February 29th total of 3,280,000 shares. Based on an average trading volume of 404,500 shares, the short-interest ratio is currently 7.5 days.March 30, 2024 | msn.comPowell: ‘No reason’ to think economy is close to recessionMarch 29, 2024 | finance.yahoo.comInvestors in BioLife Solutions (NASDAQ:BLFS) have unfortunately lost 49% over the last three yearsMarch 27, 2024 | finance.yahoo.comCorporate Insiders Are Selling These 10 Small-Cap StocksMarch 22, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Shares Up 3%BioLife Solutions (NASDAQ:BLFS) Trading Up 3%March 19, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Down 7.6% in FebruaryBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) was the target of a significant decrease in short interest in the month of February. As of February 29th, there was short interest totalling 3,280,000 shares, a decrease of 7.6% from the February 14th total of 3,550,000 shares. Based on an average trading volume of 424,300 shares, the days-to-cover ratio is presently 7.7 days.March 14, 2024 | insidertrades.comBioLife Solutions, Inc. (NASDAQ:BLFS) Director Amy Duross Sells 6,135 SharesMarch 14, 2024 | finance.yahoo.comDirector Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS)March 13, 2024 | marketbeat.comAmy Duross Sells 6,135 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) Director Amy Duross sold 6,135 shares of the business's stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $16.86, for a total transaction of $103,436.10. Following the transaction, the director now owns 34,508 shares in the company, valued at approximately $581,804.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 13, 2024 | finance.yahoo.comInsider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS)March 13, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CEO Sells 7,249 Shares of Stock Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… BLFS Media Mentions By Week BLFS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLFS News Sentiment▼0.800.57▲Average Medical News Sentiment BLFS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLFS Articles This Week▼232▲BLFS Articles Average Week Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zynex News Today Edap Tms News Today AxoGen News Today Outset Medical News Today InMode News Today Soleno Therapeutics News Today CONMED News Today Evolus News Today Tango Therapeutics News Today Cytek Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLFS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
